Newsroom

Sorted by: Latest

-

NetApp تستكمل استحواذها على PEAK:AIO لتسريع نشر حلول الذكاء الاصطناعي على نطاق زيتابايت

سان خوسيه، كاليفورنيا--(BUSINESS WIRE)--أعلنت NetApp® (المدرجة في ناسداك بالرمز: NTAP)، وهي الشركة الرائدة في مجال البنى التحتية الذكية للبيانات، اليوم عن استكمال استحواذها على شركة PEAK:AIO، الرائدة في تطوير الجيل الجديد من بنيات البيانات الوصفية وأنظمة الملفات المتوازية عالية الأداء. ومن خلال هذا الاستحواذ، ستتمكن NetApp من توظيف خدمات البيانات الوصفية والابتكارات في مجال مساحات الأسماء المتوازية لتعزيز قدرات NetApp Novus، أسرع حلول التخزين على مستوى العالم، بما يتيح دعم أنظمة الملفات على نطاق...
-

Vitesse Energy Announces Third Quarter 2026 Results

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Vitesse Energy, Inc. (NYSE: VTS) (“we,” “our,” “Vitesse,” or the “Company”) today reported the Company’s third quarter 2026 financial and operating results and revised 2026 annual guidance. THIRD QUARTER 2026 HIGHLIGHTS GAAP net loss of $36.4 million, including a non-cash unrealized loss on commodity derivatives of $46.6 million, and Adjusted Net Income(1) of $2.5 million Adjusted EBITDA(1) of $39.3 million Cash flow from operations of $39.4 million an...
-

BWX Technologies Reports Third Quarter 2026 Results

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported third quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1. "We had strong third quarter 2026 earnings performance, highlighting our intense focus on operational excellence and cash generation," said Rex. D. Geveden, president and chief executive officer. "We are in the early-stages of a multi-decadal investment cycle as our customers seek to address...
-

Hinge Health reports record third quarter 2026 financial results

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. “Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale," said Daniel Perez, Co-Founder and CEO, Hinge Health. "This focus on the triple aim, via a technology platform that scales and automates care delivery, is also...
-

Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue Growth of 96% Y/Y; Raises FY 2026 Revenue Guidance to 91% Y/Y Growth and U.S. Comm Revenue Guidance to 143% Y/Y, Crushing Consensus Expectations

MIAMI--(BUSINESS WIRE)--Palantir Technologies Inc. (NASDAQ:PLTR) today announced financial results for the third quarter ended September 30, 2026. “The Sovereign AI movement is imposing the most dramatic dichotomy between haves and have nots that I have witnessed in 30 years of business. Every institution—government and commercial—is rapidly being forced, voluntarily or not, into one of these two categories,” said Alex Karp, Co-Founder and Chief Executive Officer of Palantir Technologies. “Witn...
-

Emergent Biosolutions Reports Third Quarter 2026 Financial Results

GAITHERSBURG, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2026. “Emergent's third-quarter results, which include revenue of $110.0 million inline with our guidance, were primarily driven by our diverse biodefense/medical countermeasures and naloxone portfolio, underscoring the importance of disciplined execution as we advance our multi-year transformation,” said Joe Papa, president and chief executive of...
-

Vir Biotechnology to Participate in the Jefferies 2026 London Healthcare Conference

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, President and Chief Executive Officer, will present at the Jefferies 2026 London Healthcare Conference on Wednesday, November 18 at 10:30 a.m. GMT / 5:30 a.m. ET in London, United Kingdom.A live webcast of the fireside chat will be available at https://investors.vir.bio and will be archived for 30 days.About Vir BiotechnologyVir Biotechnology, Inc. is a clinical-stag...
-

Backblaze Announces Third Quarter 2026 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Backblaze, Inc. (Nasdaq: BLZE), the high-performance capacity storage layer for AI, today announced results for its third quarter ended September 30, 2026. “Q3 2026 was another strong quarter, with B2 revenue growth accelerating to 47% year over year, up from 28% a year ago, reflecting broad-based momentum across our customer base,” said Gleb Budman, co-founder and CEO of Backblaze. “We added a record number of net new B2 self-serve customers, four times as many...
-

Paymentus Reports Third Quarter 2026 Financial Results

DALLAS--(BUSINESS WIRE)--Paymentus Holdings, Inc. (“Paymentus”) (NYSE: PAY), a leading provider of cloud-native billing, payment, disbursement and AI-enabled Service Commerce solutions, today announced its unaudited financial results for the quarter ended September 30, 2026. “Paymentus delivered another strong quarter, with 19.8% year-over-year revenue growth. This revenue performance drove growth in contribution profit and adjusted EBITDA of 20.6% and 38.6%, respectively. Our year-to-date resu...
-

CONMED Corporation to Participate in the Jefferies Global Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Jefferies Global Healthcare Conference, which is being held November 16-19, 2026 at the Waldorf Hilton and ME Hotel in London, UK. Management will participate in a fireside chat on Monday, November 16th at 11:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time). A live audio webcast of the fireside chat will be accessible under the “Events” section of the company’s investor relations website:...